SPRTN patient variants cause global-genome DNA-protein crosslink repair defects

Nat Commun. 2023 Jan 21;14(1):352. doi: 10.1038/s41467-023-35988-1.

Abstract

DNA-protein crosslinks (DPCs) are pervasive DNA lesions that are induced by reactive metabolites and various chemotherapeutic agents. Here, we develop a technique for the Purification of x-linked Proteins (PxP), which allows identification and tracking of diverse DPCs in mammalian cells. Using PxP, we investigate DPC repair in cells genetically-engineered to express variants of the SPRTN protease that cause premature ageing and early-onset liver cancer in Ruijs-Aalfs syndrome patients. We find an unexpected role for SPRTN in global-genome DPC repair, that does not rely on replication-coupled detection of the lesion. Mechanistically, we demonstrate that replication-independent DPC cleavage by SPRTN requires SUMO-targeted ubiquitylation of the protein adduct and occurs in addition to proteasomal DPC degradation. Defective ubiquitin binding of SPRTN patient variants compromises global-genome DPC repair and causes synthetic lethality in combination with a reduction in proteasomal DPC repair capacity.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • DNA Damage* / genetics
  • DNA Repair / genetics
  • DNA-Binding Proteins* / metabolism
  • Humans
  • Mammals / genetics
  • Proteasome Endopeptidase Complex / metabolism

Substances

  • DNA-Binding Proteins
  • Proteasome Endopeptidase Complex
  • SPRTN protein, human